Anavex Life Sciences Corp (AVXL)

[Steady_T]

If the data is good then the drug will be approved. It's that simple.
Anavex has hired a very competent team to get the NDA & MAA and whatever the TGD calls their application written and submitted.

The data will garner the approval. Rett approval will be first and AD will not be that long afterwards.

We have been told the cost of producing 2-73 is low which means margins will be high and the cost to the patient will be comparatively low. Those two items assure not only revenues but profitability for both the partner and Anavex.

The company has repeatedly said it will do Rett on its own, so no splitting the revenues with a partner there. No BP required.

So DBOT, your concerns are ill founded at the least and specious at best.